Long-Term Assets: The sum of all assets classified as non-current.
Legend Biotech Corporation Sponsored ADR (LEGN) had Long-Term Assets of $470.94M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$272.33M |
|
$-39.69M |
|
$115.31M |
|
$157.02M |
|
$315.43M |
|
$-43.10M |
|
$4.03M |
|
$-39.07M |
|
$-39.07M |
|
$-39.69M |
|
$-39.69M |
|
$-39.69M |
|
$-39.69M |
|
$-43.10M |
|
$-37.22M |
|
184.64M |
|
184.64M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$1.24B |
|
$111.40M |
|
|
Long-Term Assets |
$470.94M |
$1.71B |
|
$433.57M |
|
$171.93M |
|
$268.12M |
|
$701.69M |
|
$1.01B |
|
$1.01B |
|
$1.01B |
|
184.69M |
|
| Cash Flow Statement Financials | |
$-88.00M |
|
$71.11M |
|
$0.35M |
|
$286.75M |
|
$278.89M |
|
$-7.86M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.86 |
|
-- |
|
-- |
|
0.15 |
|
0.31 |
|
57.66% |
|
-15.83% |
|
-15.83% |
|
-- |
|
-14.35% |
|
-14.57% |
|
$-104.23M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
3.95 |
|
220.33 |
|
0.41 |
|
-3.92% |
|
-3.92% |
|
-2.32% |
|
-3.35% |
|
$5.48 |
|
$-0.56 |
|
$-0.48 |
|